2,324
Views
2
CrossRef citations to date
0
Altmetric
HPV – Research Article

Factors affecting children’s HPV vaccination in Austria: Evidence from a parent survey

, ORCID Icon & ORCID Icon
Article: 2126251 | Received 15 Mar 2022, Accepted 15 Sep 2022, Published online: 17 Oct 2022

References

  • Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, Hesse BW. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med. 2015;48(4):1–11. doi:10.1016/j.amepre.2014.10.024.
  • Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26. doi:10.1016/j.bpobgyn.2017.08.006.
  • de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70. doi:10.1002/ijc.30716.
  • Vollrath K, Thul S, Holcombe J. Meaningful methods for increasing human papillomavirus vaccination rates: an integrative literature review. J Pediatr Heal Care. 2018;32(2):119–32. doi:10.1016/j.pedhc.2017.07.005.
  • Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17. doi:10.1128/CMR.16.1.1-17.2003.
  • Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009;4(1):1–8. doi:10.1186/1750-9378-4-8.
  • Guan P, Howell-Jones R, Li N, Bruni L, Sanjosé S D, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349–59. doi:10.1002/ijc.27485.
  • Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, Moreira ED, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and Intraepithelial Neoplasia in Women. N Engl J Med. 2015;372(8):711–23. doi:10.1056/nejmoa1405044.
  • Villa A, Patton LL, Giuliano AR, Estrich CG, Pahlke SC, O’Brien KK, Lipman RD, Araujo MWB. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews. J Am Dent Assoc. 2020;151(4):245–54. doi:10.1016/j.adaj.2019.10.010.
  • Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines. 2021;9(12):1413. doi:10.3390/vaccines9121413.
  • Falcaro M, Castanon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084–92. doi:10.1016/S0140-6736(21)02178-4.
  • Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–48. doi:10.1056/nejmoa1917338.
  • Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study. Int J Cancer. 2016;138(12):2867–74. doi:10.1002/ijc.30035.
  • Silverberg MJ, Leyden WA, Lam JO, Gregorich SE, Huchko MJ, Kulasingam S, Kuppermann M, Smith-McCune KK, Sawaya GF. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. Lancet Child Adolesc Heal. 2018;2(10):707–14. doi:10.1016/S2352-4642(18)30220-7.
  • Harper DM, DeMars LR. HPV vaccines – a review of the first decade. Gynecol Oncol. 2017;146(1):196–204. doi:10.1016/j.ygyno.2017.04.004.
  • Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, Avis M, Philips Z, Russell I, Whynes D, et al. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer. 2006;94(9):1253–62. doi:10.1038/sj.bjc.6603086.
  • European Centre for Disease Prevention and Control. Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction [Internet]. Stockholm; 2020. https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-on-HPV-vaccination-in-EU-countries2020-03-30.pdf.
  • Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch F, de Sanjosé S, ICO HPV Information Centre. Human papillomavirus and related diseases report. [place unknown]; 2019.
  • European Centre for Disease Prevention and Control. Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction. Stockholm; 2020. doi:10.2900/71487.
  • World Health Organisation. Human papillomavirus vaccines: wHO position paper. Geneva; 2017.
  • Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, et al. Population-Level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Heal. 2016;1(1):e8–e17. doi:10.1016/S2468-2667(16)30001-9.
  • Drolet M, É B, Pérez N, Brisson M. Population level-impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Obstet Gynecol Surv. 2019;74(10):590–92. doi:10.1097/OGX.0000000000000724.
  • Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA, Unger ER. Human papillomavirus vaccination recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Reports. 2014;63:1–30.
  • Austrian Cancer Aid. HPV - humane papillomaviren [Internet]. [place unknown]; 2020. https://www.krebshilfe.net/fileadmin/user_upload/Dachverband/Broschüren/2020_HPV___WEB.pdf.
  • Austrian Ministry of Social Affairs, Health, Care and CP. Humane Papillomaviren (HPV) [Internet]; 2020. https://www.sozialministerium.at/Themen/Gesundheit/Uebertragbare-Krankheiten/Infektionskrankheiten-A-Z/Humane-Papillomaviren-HPV.html.
  • Jančar N, Mihevc Ponikvar B, Tomšič S. Cold-Knife conisation and large loop excision of transformation zone significantly increase the risk for spontaneous preterm birth: a population-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2016;203:245–49. doi:10.1016/j.ejogrb.2016.06.005.
  • Borena W, Luckner-Hornischer A, Katzgraber F, Holm-von Laer D. Factors affecting HPV vaccine acceptance in west Austria: do we need to revise the current immunization scheme? Papillomavirus Res. 2016;2:173–77. doi:10.1016/j.pvr.2016.10.001.
  • World Health Organisation. Cervical cancer elimination initiative [Internet]; 2020. https://www.who.int/initiatives/cervical-cancer-elimination-initiative.
  • Marlow LAV, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013;31(5):763–69. doi:10.1016/j.vaccine.2012.11.083.
  • Bianco A, Pileggi C, Iozzo F, Nobile CGA, Pavia M. Vaccination against human papilloma virus infection in male adolescents: knowledge, attitudes, and acceptability among parents in Italy. Hum Vaccines Immunother. 2014;10(9):2536–42. doi:10.4161/21645515.2014.969614.
  • Marić G, Birčanin Đ, Kisić V, Dotlić J, Zarić M, Kisić-Tepavčević D, Gazibara T. Parental perspective on human papillomavirus (HPV) vaccination in Serbia: knowledge, attitudes and practice. Sex Reprod Healthc. 2018;16(April):192–98. doi:10.1016/j.srhc.2018.04.010.
  • Thomas TL, Higgins M, Pinto M. Parental attitudes towards human papillomavirus (HPV) vaccination of boys: quantitative and qualitative results to guide development of effective HPV vaccine interventions. J Adolesc Heal. 2014;54(2):86. doi:10.1016/j.jadohealth.2013.10.185.
  • Farsi NJ, Al Sharif S, Al Qathmi M, Merdad M, Marzouki H, Merdad L. Knowledge of Human Papillomavirus (HPV) and oropharyngeal cancer and acceptability of the HPV vaccine among dental students. Asian Pacific J Cancer Prev. 2020;21(12):3595–603. doi:10.31557/APJCP.2020.21.12.3595.
  • Lee YM, Riesche L, Lee H, Shim K. Parental HPV knowledge and perceptions of HPV vaccines among Korean American parents. Appl Nurs Res [Internet]. 2018;44(May):54–59. doi:10.1016/j.apnr.2018.09.008.
  • State of Tyrol. Übersicht aller Schulen Tirols [Internet]; 2021. https://www.tirol.gv.at/bildung/uebersicht-aller-tiroler-schulen/.
  • Zimet GD. Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol. 2006;18(1):23–28. doi:10.1097/01.gco.0000216317.10690.8f.
  • Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AAW. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine. 2011;29(44):7785–93. doi:10.1016/j.vaccine.2011.07.107.
  • Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197–204. doi:10.1097/OLQ.0b013e3181f12dbf.
  • Rickert A VI, Ba CD, Rosenthal SL, Rupp RE, Zimet GD, Zimet GD. School-Based HPV immunization of young adolescents: effects of two brief health interventions. Hum Vaccines Immunother. 2015;11(2):315–21. doi:10.1080/21645515.2014.1004022.
  • Auslander BA, Meers JM, Short MB, Rosenthal SL, Zimet GD. A qualitative analysis of the vaccine intention-behaviour relationship: parents’ descriptions of their intentions, decision-making behaviour and planning processes towards HPV vaccination. Psychol Health. 2017;34(3):271–88. doi:10.1080/08870446.2018.1523408.
  • Gabutti G, Anchera E, De Motoli F, Savio M, Stefanati A. Human papilloma virus vaccination: focus on the Italian situation. Vaccines. 2021;9(12):1374. doi:10.3390/vaccines9121374.
  • Austrian Ministry of Social Affairs, Health, Care and CP. Die Elektronische Gesundheitsakte (ELGA) [Internet]; 2021. https://www.gesundheit.gv.at/elga/inhalt.
  • Waller J, Forster A, Ryan M, Richards R, Bedford H, Marlow L. Decision-Making about HPV vaccination in parents of boys and girls: a population-based survey in England and Wales. Vaccine. 2020;38(5):1040–47. doi:10.1016/j.vaccine.2019.11.046.
  • Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11. doi:10.1056/nejmoa0909537.
  • Paul KT. “Saving lives”: adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria. Soc Sci Med. 2016;153:193–200. doi:10.1016/j.socscimed.2016.02.006.
  • Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccines Immunother. 2019;15(7–8):1615–27. doi:10.1080/21645515.2018.1564436.
  • Austrian Federation of Social Insurances. HPV impfung [Internet]; 2016. https://www.sozialversicherung.at/cdscontent/?contentid=10007.844237&portal=svportal.
  • Teoh D. The power of social media for HPV vaccination–not fake news! Am Soc Clin Oncol Educ B. 2019;39(39):75–78. doi:10.1200/edbk_239363.
  • Slovic P, Peters E. Risk perception and affect. Curr Dir Psychol Sci. 2006;15(6):322–25. doi:10.1111/j.1467-8721.2006.00461.x.
  • Sobo EJ. Social cultivation of vaccine refusal and delay among Waldorf (Steiner) school parents. Med Anthropol Q. 2015;29(3):381–99. doi:10.1111/maq.12214.
  • Siegrist M, Cvetkovich G. Better negative than positive? Evidence of a bias for negative information about possible health dangers. Risk Anal. 2001;21(1):199–206. doi:10.1111/0272-4332.211102.
  • World Health Organisation. Safety update of HPV vaccines. [place unknown]; 2017. https://www.who.int/vaccine_safety/committee/topics/hpv/June_2017/en/.
  • Reno JE, O’Leary S, Garrett K, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, Dempsey AF. Improving provider communication about HPV vaccines for vaccine-hesitant parents through the use of motivational interviewing. J Health Commun. 2018;23(4):313–20. doi:10.1080/10810730.2018.1442530.
  • Wegwarth O, Kurzenhäuser-Carstens S, Gigerenzer G. Overcoming the knowledge-behavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine [Internet]. 2014;32(12):1388–93. doi:10.1016/j.vaccine.2013.12.038.
  • Dreyer G, Der Merwe FH V, Botha MH, Snyman LC, Constant D, Visser C, Harvey J. School-Based human papillomavirus vaccination: an opportunity to increase knowledge about cervical cancer and improve uptake of screening. South African Med J. 2015;105(11):912–16. doi:10.7196/SAMJ.2015.v105i11.9814.
  • Wirtz C, Mohamed Y, Engel D, Sidibe A, Holloway M, Bloem P, Kumar S, Brotherton J, Reis V, Morgan C. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review. Vaccine [Internet]. 2022;40:A116–A123. doi:10.1016/j.vaccine.2021.11.013.
  • Lin CJ, Nowalk MP, Toback SL, Rousculp MD, Raymund M, Ambrose CS, Zimmerman RK. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine. 2010;28(48):7706–12. doi:10.1016/j.vaccine.2010.07.009.
  • Anello P, Cestari L, Baldovin T, Simonato L, Frasca G, Caranci N, Grazia Pascucci M, Valent F, Canova C. Socioeconomic factors influencing childhood vaccination in two northern Italian regions. Vaccine. 2017;35(36):4673–80. doi:10.1016/j.vaccine.2017.07.058.
  • Arat A, Burström B, Östberg V, Hjern A. 2019. Social inequities in vaccination coverage among infants and pre-school children in Europe and Australia - a systematic review. BMC Public Health. 19(1). doi:10.1186/s12889-019-6597-4.
  • Pedersen EA, Loft LH, Jacobsen SU, Søborg B, Bigaard J. Strategic health communication on social media: insights from a Danish social media campaign to address HPV vaccination hesitancy. Vaccine. 2020;38(31):4909–15. doi:10.1016/j.vaccine.2020.05.061.
  • Cates J, Shafer A, Diehl S, Deal A. Evaluating a county-sponsored social marketing campaign to increase mothers’ initiation of HPV vaccine for their pre-teen daughters in a primarily rural area. Soc Mar Q [Internet]. 2011;17(1):4–26. doi:10.1080/15245004.2010.546943.
  • Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1):65–71. doi:10.1016/j.chest.2020.03.012.
  • Bauhoff S. Systematic self-report bias in health data: impact on estimating cross-sectional and treatment effects. Heal Serv Outcomes Res Methodol. 2011;11(1):44–53. doi:10.1007/s10742-011-0069-3.